What We Offer 

MWDH offers a web and app digital platform to self-manage chronic cardiometabolic diseases (including Diabetes) by integrating data from hospitals and home devices, analysing the data and providing personal insights and recommended actions. This has been shown to improve patient outcomes and experience while lowering cost.  

In KSA, Diabetes itself is >20% of the population and another 20% are pre-diabetic with costs estimated at ~$200 Billion a year and expected to double in next 20 years.  

What We Are Looking For 

MWDH is already live in KSA having launched in 1 private hospital chain’s flagship hospital in Riyadh and a confirmed public contract with 1 of the 20 geographic Health Cluster regions in the north of the country.  

MWDH seeks to serve more/other private hospitals and other 19 geographic Health Clusters. In addition, we are also interested in potential partnerships with commercial companies in this cardiometabolic disease (especially Diabetes) area for a direct to consumer business such as glucose monitor companies like Abbott and Dexcom and Medtronic.